From July 1, 2023 to September 30, 2023, the company has repurchased 175,910 shares, representing 0.22% for $0.4 million. With this, the company has completed the repurchase of 3,056,903 shares, representing 3.86% for $5.8 million under the buyback announced on November 28, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.465 USD | +1.02% | -0.98% | +13.80% |
Apr. 25 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Apr. 25 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.80% | 933M | |
+8.45% | 219B | |
+7.17% | 183B | |
+11.70% | 133B | |
+26.24% | 108B | |
+1.44% | 63.06B | |
+14.26% | 52.02B | |
-0.62% | 48.2B | |
+0.17% | 40.37B | |
+12.58% | 39.35B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on November 28, 2022.